GlaxoSmithKline PLC Publication of a Prospectus (8797L)
04 Mayo 2020 - 11:40AM
UK Regulatory
TIDMGSK
RNS Number : 8797L
GlaxoSmithKline PLC
04 May 2020
Issued: 4 May 2020, London UK - LSE Announcement
Publication of Supplementary Prospectus
The following supplementary prospectus dated 30 April 2020 has
been approved by the UK Listing Authority and is available for
viewing:
GlaxoSmithKline plc, GlaxoSmithKline Capital plc and GSK Capital
K.K. GBP20,000,000,000 Euro Medium Term Note Programme
Copies of the supplementary prospectus and the documents
incorporated by reference within it have been submitted to
submitted to the UK Listing Authority's NSM submission portal via
the Electronic Submission System (ESS). A copy can be viewed
at:
https://data.fca.org.uk/#/nsm/nationalstoragemechanism .
For further information, please contact:
GlaxoSmithKline plc
980 Great West Road
Brentford
Middlesex
TW8 9GS
United Kingdom
BASIS ON WHICH YOU MAY ACCESS THE SUPPLEMENTARY PROSPECTUS
Please note that the information contained in the supplementary
prospectus may be addressed to and/or targeted at persons who are
residents of particular countries (specified in the base
prospectus) only and is not intended for use and should not be
relied upon by any person outside these countries and/or to whom
the offer contained in the base prospectus is not addressed. Prior
to relying on the information contained in the supplementary
prospectus you must ascertain from the base prospectus whether or
not you are part of the intended addressees of the information
contained therein.
Your right to access this service is conditional upon complying
with the above.
GlaxoSmithKline plc
Registered in England & Wales:
No. 3888792
Registered Office:
980 Great West Road
Brentford, Middlesex
TW8 9GS
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
PDIBLGDURXGDGGS
(END) Dow Jones Newswires
May 04, 2020 12:40 ET (16:40 GMT)
Gsk (LSE:GSK)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Gsk (LSE:GSK)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024